enGene Therapeutics Inc.
ENGN·NasdaqCM
1.7000−0.0300 (−1.73%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close1.7300
Open1.7300
Day range1.69001.7400
52-week range1.400012.2500
Off day high−2.30%
Off 52-week high−86.12%
Volume462.72K
Avg. volume (3M)736.63K
Market cap113.93M
EPS (TTM)-2.07
Forward P/E-1.17
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding67.02M
Short interest—
Earnings dateSep 8, 2026 (est.)
Analyst target—
Profit margin—
Against its peers
Compare in full ›| ENGN | ONCY | TRDA | CADL | CSBR | PLYX | |
|---|---|---|---|---|---|---|
| Market cap | 113.93M | 62.06M | 214.15M | 748.35M | 68.94M | 100.19M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.2 | -2.4 | -1.8 | -15.6 | 49.5 | — |
| Price/book | 0.5 | -9.7 | 0.8 | 5.9 | 17.7 | 9.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −79.13% | −52.14% | −2.41% | +53.63% | −25.65% | −94.29% |
| Today | −1.73% | −15.03% | −3.00% | −1.61% | −0.54% | +0.50% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ENGN news ›No recent coverage in the 4Search index.
From articles in the 4Search news index.